Get enquiries on WhatsApp WhatsApp
22 Aug 2019

Reply

Looking for a CDMO to develop Imatinib Mesylate Tablets/Capsules (120 mg) in the United States [ENA04955]
A specialty patient-centric life sciences company with a focus on novel and innovative drug delivery technologies that improve the clinical outcome in rare and orphan disease treatment is looking for a CDMO to develop Imatinib Mesylate tablets/Capsules (120 mg) for Phase 3 Clinical Study in the United States for IND registration. The formulation needs to be tableted or encapsulated and packaged for clinical studies in the US and EU.

Comments :

NouryonChemltd@gmail.com

For more details please email us NouryonChemltd@gmail.com
SKYPE ID. NouryonChemltd
Tel: +1571-399-6898

02:56,  23 Aug 2019

deepakmamtora@gmail.com

Dear Sir,

kidnly send your contact details to take this ahead, please mail on deepakmamtora@gmail.com or whatsapp on +91 9833223402.

11:50,  23 Aug 2019

prakash@saviopharma.in

We can able to provide.
Please send your requirements to below email
Saviopharma.in@gmail.com

12:07,  30 Aug 2019

prakash@saviopharma.in

We can able to provide.
Please send your requirements to below email
Saviopharma.in@gmail.com

12:07,  30 Aug 2019

mustafa.shwayat@gmail.com

Dear Sir,
Kindly send me your contact details so that I can communicate with you regarding the mentioned project.
we have a comprehensive solution for your request.
my email. mustafa.shwayat@gmail.com
once we communicate I can send you my professional email
Best Regards

17:28,  03 Sep 2019

juraj.jerkovic@gen-plus.de

Gen-Plus is a CDMO located in Münich, Germany. We are fully capable to develop the product in question.

18:18,  09 Sep 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty